M1 Kliniken AG (MKLNF) Research

M1 Kliniken AG, along with its affiliated entities, delivers aesthetic and plastic surgery services through a network of medical facilities spanning Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, and Australia. The company structures its operations into two core divisions: Beauty and Trade. Under its Beauty segment, M1 develops and commercializes a range of pharmaceutical, medical, and medical technology products designed for aesthetic medicine and cosmetic dermatology. These products are distributed to healthcare professionals, pharmacies, and wholesalers under the "M1 Select" brand. The Trade segment focuses on the broad commercial distribution of diverse medical products, including pharmaceuticals, biosimilars, and various medical devices. This trading activity covers critical therapeutic areas such as oncology, HIV treatment, rheumatology, neurology, cardiovascular diseases, and controlled substances. Furthermore, the company is involved in real estate, specifically the acquisition, management, and sale of properties, with a predominant focus on the healthcare sector. M1 Kliniken AG's service infrastructure includes a specialized surgical clinic and approximately 46 dedicated specialist centers operating under the M1 Med Beauty brand. Founded in 2007 and headquartered in Berlin, Germany, M1 Kliniken AG functions as a subsidiary of MPH Health Care AG.

Open M1 Kliniken AG (MKLNF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.